Updated 08:05 GMT, 20 Nov 2026 SPX 7,175.83 -2.02% NDX 26,517.05 -2.21% VIX 28.44 +15.80% GOLD 3,574.90 -3.00% CL 82.63 -0.70% BTC 61,735.58 -0.27%
NAS100 26,517 −2.21% S&P 7,176 −2.02% GOLD $3,575 −3.00% BTC $61,736 −0.27% VIX 28.44 +15.80% latest tape · as of 08:05 UTC
The Screen · Energy · Oil & Gas Refining & Marketing

Marathon Petroleum logoMarathon Petroleum

MPC · a US exchange · USD · Market cap $106.1B · 18,500 employees

Marathon Petroleum Corporation, together with its subsidiaries, operates as an integrated downstream energy company in the United States.

FAIL · Does not pass the screen
367.93 USD

Price as of 19 Nov 2026Daily close, not a live quote

Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price367.93 USD at the 19 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 19 Nov 2026
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans to puts (put/call 2.61)
  • Last reviewed19 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $389.24 to $598.18, base estimate $492.50 (screen dated 2026-11-19).

Current read
Distribution ?
Undervalued · screened 2026-11-19
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning political selling, disclosed 2026-10-15
  • Options put/call open interest 2.61, read 2026-11-19
  • Ethical does not pass the values gate
Price367.93 USD
Fair value492.50
Ethical score10.0/100
Value readUndervaluedas of 19 Nov 2026
Our investment reviews on this name
2026-11-10Read Distribution389.88-5.6% to today ✓Markup gives way to Distribution after a 49% rise in 19 weeks
2026-07-02Read Markup262.01+40.4% to today ✓First review on file: Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Marathon Petroleum holds its Distribution at $367.93. Elevated stress, defensive posture warranted, held for 11 days.

As held on the ledger · 2026-11-19
PhaseDistribution · caution
Quantitative stateElevated stress, defensive posture warranted, held for 11 days
Price at the screen$367.93
Valuation7.72 trailing · 6.34 forward price to earnings
Values screenFAIL · score 10.0
Beta0.51
The Workings

Five Screens: MPC's Results

FAIL. Debt ratio

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 40.92% Below 33% Fail
Interest-bearing cash 8.09% Below 33% Pass
Receivables 16.66% Below 49% Pass
Revenue purity 0.12% Below 5% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Falls Short, in Plain English

Marathon Petroleum's business is in a permissible area, but its interest-bearing debt is about 41% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when MPC's ethical verdict changes

Today MPC does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 19 Nov 2026: it trades at roughly a 25% discount to our $492.50 fair value, weak competitive moat, 60.90% revenue growth.

Model construction and limits: fair-value methodology.

389.24Conservative492.50Base case598.18Growth case 367.93Price

Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 25.3% discount to the base estimate.

The Street's Range
236.00Street low 466.00Street average 564.00Street high 367.93Price

Third-party analyst targets: 17 covering, consensus Buy. The average target sits +27% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $492.50, with a range of $389.24 to $598.18, dated to the 2026-11-19 screen.

How our estimate and third-party targets differ.

The Business, in Plain Words

US refiner looks cheap but carries heavy debt

Every time crude prices spike, refiners book fat margins that vanish the moment demand softens or inventories build. We pass on Marathon because the 12.4 times forward multiple sits on what looks like peak-cycle earnings, not a durable edge, and the business carries a weak moat with just 3 percent profit margins despite 9 percent revenue growth.

Return on equity reaches 27 percent, yet that figure flatters a capital-heavy model exposed to oil swings. The shares trade 18 percent above our fair value of 256.78 against a 312.60 price, and the ethical screen flags the debt ratio as a clear failure.

Seventeen analysts still rate it a buy with a 300 median target, but cyclical value traps often appear cheapest right before earnings roll over. Debt adds fragility when fuel cracks narrow. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E6.3xcheap for a company growing this fast
Trailing P/E7.7xvery cheap relative to earnings
EPS, trailing50.47
EPS, forward61.42
Revenue growth+60.9%growing very fast
Profit margin8.3%thin but positive margins
Return on equity60.5%an exceptional return on shareholder capital
FCF yield15.31%
Dividend yield1.18%
Debt to equity1.15a meaningful debt load worth watching
Current ratio1.45adequate liquidity, worth monitoring
Beta0.51steadier than the market
Short interest, float0.03%
52-week range161.93 - 493.98
MoatWEAK
Market cap$106.1B
Employees18,500

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-17 Distribution $414.65 +6.4% Entry 24

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 6.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $458.

2026-11-10 Distribution · changed $389.88 -12.3% Entry 23

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 12.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (17 analysts) rates it buy, with a mean price target of $467.

2026-11-03 Markup $444.73 +0.0% Entry 22

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-02 Markup $444.73 +0.0% Entry 21

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-01 Markup $444.73 +2.8% Entry 20

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-31 Markup $432.51 +0.0% Entry 19

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-30 Markup $432.51 -5.4% Entry 18

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 5.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-29 Markup $457.22 -4.1% Entry 17

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-28 Markup $476.92 +0.0% Entry 16

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-27 Markup $476.92 +0.0% Entry 15

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 70% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (18 analysts) rates it buy, with a mean price target of $459. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on MPC

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in MPC's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · MPC
DateInsiderTitleTypeSharesValue
2026-05-13 HESSLING RICKY D. Officer 1,000 $250,000
2026-04-30 ELLISON-TAYLOR KIMBERLY N Director 727 ·
2026-04-30 PATERSON EILEEN PATRICIA Director 727 ·
2026-04-30 RUCKER KIM K. W. Director 727 ·
2026-04-30 SEMPLE FRANK M Director 727 ·
2026-04-30 SURMA JOHN P JR. Director 727 ·
2026-04-30 COHEN JONATHAN Z Director 727 ·
2026-04-30 STICE J MICHAEL Director 727 ·
2026-04-30 CAMPBELL JEFFREY C Director 727 ·
2026-04-30 BAYH B EVAN III Director 727 ·

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming MPC
DatePoliticianPartyTypeAmount
2026-10-15 David Taylor Republican sell 1K–15K
2026-10-15 David Taylor Republican sell 1K–15K
2026-10-15 David Taylor Republican sell 1K–15K
2026-10-15 David Taylor Republican sell 1K–15K
2026-10-15 David Taylor Republican sell 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $473.69 -21.1% · $789 -21.1%
2 months $424.89 -12.0% · $880 -12.0%
3 months $358.23 +4.4% · $1,044 +4.4%
6 months $253.95 +47.2% $1.00 $1,476 +47.6%
1 year $196.33 +90.4% $4.00 $1,925 +92.5%
2 years $153.76 +143.1% $7.64 $2,481 +148.1%
3 years $140.17 +166.7% $10.12 $2,739 +173.9%
5 years $54.40 +587.2% $15.68 $7,160 +616.0%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever MPC does next, these words stay.

Marathon Petroleum · MPC · Distribution · $367.93
Recorded 2026-11-19 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.